Sanger Sequencing Service Market Growth, Share, Size, Demand, New Technology, Challenges and Trends Analysis till 2027

Sanger sequencing is the superior method for sequencing, and it is a process of incorporation of chain-terminating dideoxynucleotides by DNA polymerase during in vitro DNA replication. Sanger sequencing is known to provide high accuracy, long-read capabilities, and adaptability to support a diverse range of applications in many research areas. Sanger sequencing is mainly recognized for DNA sequencing and supports applications in RNA sequencing and epigenetic analysis.

In many clinical studies, in different groups of subjects, substantive insights have been made by comparing the primary DNA sequences of genes. For example, As per Thermo Fisher Scientific, a recent study showed that up to 2% of the variants detected by NGS were not reproducible by Sanger sequencing. Therefore, in many clinical studies before a firm conclusion from variants identified by NGS, it should be confirmed by an orthogonal method. Reference materials sequenced by Sanger approaches provide ground truth against which the NGS assay can be benchmarked.

Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPRE00007514/?openpr-10144

Biomarkers and cancer led the global Sanger sequencing service market by application. In 2018, the biomarkers and cancer segment held the largest share of the market, by application. However, the personalized medicine segment is expected to grow at the fastest rate during the forecast period due to increasing emphasis on tracking down the cause of genetic disorders, along with the need to offer better treatment to these conditions.

The major players operating in the Sanger sequencing service market include Microsynth AG, Laragen, Inc., StarSEQ GmbH, Thermo Fisher Scientific, Inc., LGC Biosearch Technologies, Fasteris SA, Quintara Biosciences, GENEWIZ, GenScript, and SciGenom Labs among others. The market of Sanger sequencing service has witnessed various organic developments during recent years. During September 2019, GENEWIZ, a Brooks Life Sciences Company, declared the opening of its European headquarters for its genomics business in Germany. The facility will provide onsite Sanger sequencing and next-generation sequencing services.

Sanger sequencing service market is expected to reach US$ 1,360.47 Mn in 2027 from US$ 489.43 Mn in 2018. The market is forecasted to grow with a CAGR of 12.2% during 2019-2027. The report highlights the trends prevalent in the global Sanger sequencing service market and the factors driving the market along with those that act as deterrents to its growth.

Table of Content:

Sanger Sequencing Service Market - Key Takeaways
Research Methodology
Sanger Sequencing Service - Market Landscape
Sanger Sequencing Service Market - Key Dynamics
Sanger Sequencing Service Market - Global Analysis
Sanger Sequencing Service Market Analysis And Forecasts To 2027 - Application
Global Sanger Sequencing Service Market Analysis - By End User
Sanger Sequencing Service Market Revenue And Forecasts To 2027 - Geographical Analysis
Sanger Sequencing Service Market - Industry Landscape
Sanger Sequencing Service Market - Key Company Profiles

Buy This Report @ https://www.theinsightpartners.com/buy/TIPRE00007514/?openpr-10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.